<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): October 1, 2000
Inamed Corporation
------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Charter)
Delaware 001-09741 59-0920629
-------------------------------------------------------------------------------
(State or Other Juris- (Commission File (IRS Employer
diction of Incorporation) Number) Identification No.)
5540 Ekwill Street - Suite D, Santa Barbara, California 93111-2919
------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number: (805) 692-5400
N/A
------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
<PAGE> 2
Item 5. Other Events.
On October 1, 2000, Inamed Corporation (the "Company") and Medical
Products Development, Inc. ("MPDI") agreed to settle all of the outstanding
litigation between them. For a description of the litigation, see note 13 to
the Company's 1999 financial statements, contained on page F-24 of the
Company's 1999 Form 10-K. As part of the settlement the Company agreed to
purchase all of the U.S. patents owned by MPDI relating to texturing of breast
implants and reconstruction devices, as well as the related foreign
counterparts and reissue applications. On a fully diluted, fully taxed, basis
the acquisition of these patents will have an annual impact of $0.07 per share
(beginning in the fourth quarter of 2000) for a period of years. However, with
the litigation now settled, the Company anticipates offsetting a significant
portion of that cost through higher prices and/or product improvements.
Item 7. Financial Statements and Exhibits.
(a) Financial Statements
Not Applicable
(b) Pro Forma Financial Information
Not Applicable
(c) Exhibits
None.
2
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
INAMED CORPORATION
Date: October 4, 2000 By: /s/ David E. Bamberger
-----------------------------------------
Name: David E. Bamberger
Title: Senior Vice President, Secretary
and General Counsel
3
